Reported about 18 hours ago
Billionaire investor Ken Griffin has bought 7.9 million shares of Pfizer, increasing his stake in the struggling pharmaceutical company by 63%. Pfizer is facing challenges from declining COVID treatment sales and upcoming patent expirations, but it is looking to enter the lucrative weight loss market with its GLP-1 candidate, Danuglipron. Despite current short-term risks, Griffin's investment suggests confidence in Pfizer's potential recovery and growth.
Source: YAHOO